Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹216 Cr
up ₹2.6 Cr vs Aug 2019
- Stocks held
- 22
- unchanged
- Top 10 weight
- 64.7%
- of the portfolio in its ten largest
- Cash & debt
- 2.0%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 6
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In September 2019 it disclosed 22 stocks worth ₹216 Cr, up ₹2.6 Cr from Aug 2019. Its largest positions were Sun Pharmaceutical Industries Limited (12.2%), IPCA Laboratories Limited (9.9%), Dr. Reddy's Laboratories Limited (8.9%); the ten largest together made up 64.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 69.2% of its equity. Cash and debt stood at 2.0%. Compared with Aug 2019 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
29%
Holds more cash than 29% of peers
What these mean: concentration · cash
Holdings in September 2019
Download CSVEvery line the fund disclosed, with the change against Aug 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 12.25% | down 2.09 pts | ₹26.5 Cr | down ₹4.1 Cr | Trimmed |
| IPCA Laboratories Limited | 9.95% | down 0.12 pts | ₹21.5 Cr | up ₹1 L | Held |
| Dr. Reddy's Laboratories Limited | 8.94% | up 0.38 pts | ₹19.3 Cr | up ₹1 Cr | Added |
| Divi's Laboratories Limited | 6.91% | up 0.09 pts | ₹14.9 Cr | up ₹36 L | Added |
| Apollo Hospitals Enterprise Limited | 5.96% | down 0.01 pts | ₹12.9 Cr | up ₹12 L | Added |
| JB Chemicals & Pharmaceuticals Limited | 4.75% | down 0.21 pts | ₹10.3 Cr | down ₹34 L | Trimmed |
| Indoco Remedies Limited | 4.54% | up 0.20 pts | ₹9.8 Cr | up ₹55 L | Added |
| Max India Limited | 3.84% | up 0.20 pts | ₹8.3 Cr | up ₹53 L | Added |
| Unichem Laboratories Limited | 3.78% | up 0.11 pts | ₹8.2 Cr | up ₹34 L | Added |
| Procter & Gamble Health Limited | 3.74% | up 0.42 pts | ₹8.1 Cr | up ₹100 L | Added |
| Jubilant Pharmova Limited | 3.71% | up 0.66 pts | ₹8 Cr | up ₹1.5 Cr | Added |
| Alembic Pharmaceuticals Limited | 3.38% | up 0.04 pts | ₹7.3 Cr | up ₹16 L | Added |
| Abbott India Limited | 3.10% | up 0.39 pts | ₹6.7 Cr | up ₹91 L | Added |
| Ajanta Pharma Limited | 3.09% | down 0.07 pts | ₹6.7 Cr | down ₹8 L | Trimmed |
| Alkem Laboratories Limited | 3.05% | up 0.10 pts | ₹6.6 Cr | up ₹30 L | Added |
| Abbott Laboratories | 2.97% | up 0.09 pts | ₹6.4 Cr | up ₹27 L | Added |
| Abiomed Inc | 2.78% | down 0.02 pts | ₹6 Cr | up ₹4 L | Added |
| Syngene International Limited | 2.71% | down 0.03 pts | ₹5.9 Cr | up ₹1 L | Held |
| Torrent Pharmaceuticals Limited | 2.51% | down 0.09 pts | ₹5.4 Cr | down ₹13 L | Trimmed |
| Aarti Drugs Limited | 2.45% | down 0.09 pts | ₹5.3 Cr | down ₹14 L | Trimmed |
| Dr. Lal Path Labs Limited | 2.03% | up 0.45 pts | ₹4.4 Cr | up ₹1 Cr | Added |
| Cash, TREPS & receivables | 2.02% | down 0.32 pts | ₹4.4 Cr | down ₹63 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 1.54% | down 0.08 pts | ₹3.3 Cr | down ₹13 L | Trimmed |
What changed, Aug 2019 to Sep 2019
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Jubilant Pharmova Limitedup ₹1.5 Cr (+0.66% pts)
- Dr. Reddy's Laboratories Limitedup ₹1 Cr (+0.38% pts)
- Dr. Lal Path Labs Limitedup ₹1 Cr (+0.45% pts)
- Procter & Gamble Health Limitedup ₹100 L (+0.42% pts)
- Abbott India Limited ₹91 L (+0.39% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2019, the weight rose most in Healthcare Services (+0.5 pts) and Pharmaceuticals (+0.4 pts), and fell most in Pharmaceuticals & Biotechnology (−0.8 pts).
- Healthcare Services17.1% → 17.7%+0.5 pts
- Pharmaceuticals11.1% → 11.5%+0.4 pts
- Pharmaceuticals & Biotechnology70.1% → 69.2%−0.8 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2019 | Jun 2019 | Aug 2019 | Sep 2019 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.6% | 70.0% | 70.1% | 69.2% |
| Healthcare Services | 15.1% | 16.2% | 17.1% | 17.7% |
| Pharmaceuticals | 11.9% | 11.7% | 11.1% | 11.5% |
| Insurance | 2.3% | 2.1% | 1.7% | 1.6% |
Allocation in Sep 2019change vs Aug 2019
- Pharmaceuticals & Biotechnology (13)69.2%▼ 0.8 pts
- Healthcare Services (5)17.7%▲ 0.5 pts
- Pharmaceuticals (3)11.5%▲ 0.4 pts
- Insurance (1)1.6%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Sep 2019
2.0%
▼ 0.3 pts vs Aug 2019
- Cash alone
- 2.0%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 2.0% – 28.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.